Analysts think CLGN stock price could increase by 135%
Aug 30, 2024, 6:25 AM
-9.21%
What does CLGN do
CollPlant Biotechnologies specializes in regenerative and aesthetic medicine, offering products for tissue regeneration and organ production. Their technology relies on plant-based production of collagen type I (rhCollagen).
4 analysts think CLGN stock price will increase by 134.81%. The current median analyst target is $12.75 compared to a current stock price of $5.43. The lowest analysts target is $11.11 and the highest analyst target is $14.70.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
